Columbus Macro LLC Has $2.17 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Columbus Macro LLC boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 55.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,319 shares of the company’s stock after acquiring an additional 6,510 shares during the period. Columbus Macro LLC’s holdings in Cardinal Health were worth $2,167,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Resonant Capital Advisors LLC grew its holdings in Cardinal Health by 1.9% during the 4th quarter. Resonant Capital Advisors LLC now owns 8,698 shares of the company’s stock valued at $1,029,000 after buying an additional 160 shares in the last quarter. HHM Wealth Advisors LLC raised its stake in Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after buying an additional 144 shares during the last quarter. Burford Brothers Inc. purchased a new position in Cardinal Health in the 4th quarter worth about $1,256,000. Valley National Advisers Inc. grew its position in Cardinal Health by 1.3% during the fourth quarter. Valley National Advisers Inc. now owns 15,999 shares of the company’s stock valued at $1,891,000 after buying an additional 207 shares during the period. Finally, U.S. Capital Wealth Advisors LLC lifted its holdings in Cardinal Health by 12.2% during the fourth quarter. U.S. Capital Wealth Advisors LLC now owns 3,738 shares of the company’s stock valued at $442,000 after purchasing an additional 406 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $125.56 on Tuesday. The firm has a 50-day moving average of $122.11 and a 200 day moving average of $114.53. The stock has a market cap of $30.33 billion, a P/E ratio of 23.43, a price-to-earnings-growth ratio of 1.46 and a beta of 0.63. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Research analysts expect that Cardinal Health, Inc. will post 7.92 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.61%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analysts Set New Price Targets

CAH has been the topic of several research reports. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Mizuho began coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target for the company. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Morgan Stanley increased their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $135.64.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.